Report Open Access

Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19

Elvidge, Jamie; Summerfield, Ashley; Knies, Saskia; Németh, Bertalan; Kaló, Zoltán; Goettsch, Wim; Dawoud, Dalia


MARC21 XML Export

<?xml version='1.0' encoding='UTF-8'?>
<record xmlns="http://www.loc.gov/MARC21/slim">
  <leader>00000nam##2200000uu#4500</leader>
  <datafield tag="041" ind1=" " ind2=" ">
    <subfield code="a">eng</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Health Technology Assessment (HTA)</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">COVID-19</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Diagnostics</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Treatments</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Clinical effectiveness</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Cost effectiveness</subfield>
  </datafield>
  <datafield tag="653" ind1=" " ind2=" ">
    <subfield code="a">Value Framework</subfield>
  </datafield>
  <controlfield tag="005">20211006130820.0</controlfield>
  <controlfield tag="001">5530468</controlfield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">2.	Medicines Analysis, NHS England and NHS Improvement, UK</subfield>
    <subfield code="a">Summerfield, Ashley</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">3.	National Health Care Institute (Zorginstituut Nederland), Netherlands</subfield>
    <subfield code="a">Knies, Saskia</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">4.	Syreon Institute, Hungary</subfield>
    <subfield code="a">Németh, Bertalan</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">4.	Syreon Institute, Hungary</subfield>
    <subfield code="a">Kaló, Zoltán</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">3.	National Health Care Institute (Zorginstituut Nederland), Netherlands,5.	Utrecht Centre for Pharmaceutical Policy, Utrecht University, Netherlands</subfield>
    <subfield code="a">Goettsch, Wim</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">1. Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE)</subfield>
    <subfield code="0">(orcid)0000-0002-2105-1937</subfield>
    <subfield code="a">Dawoud, Dalia</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Past Chair of HTAi Patient and Citizen Involvement Interest Group, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Bertelsen, Neil</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">NHS Healthcare Improvement Scotland, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Brown, Alisa</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Institute for Clinical and Effectiveness Research (ICER), USA</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Campbell, Jon D</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">International Society for Pharmacoeconomics and Outcomes Research (ISPOR), USA</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Cabra, Arturo</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">McGill University, Canada</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Caro, Jaime</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Erasmus University, Netherlands</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Dijk, Stijntje</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">NHS Forth Valley, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Foster, Trudy</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Gilead Sciences, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Graham, Peter</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Erasmus University, Netherlands</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Krijkamp, Eline</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">NHS County Durham, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Larcombe, James</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">NHS Healthcare Improvement Scotland, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Lee, Anne</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">British Thoracic Society, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Messer, Ben</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">BioMereux, France</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Miller, Mark</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">MSD, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Ntais, Dionysios</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Chair of the ISPOR Health Technology Assessment Council, Canada</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">O'Rourke, Brian</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Ministry of Healthcare, Ukraine</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Piniazhko, Oresta</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">NHS England and NHS Improvement, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Pinwill, Nina</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">Andalusian Health Technology Assessment Unit (AETSA), Spain</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Rejón-Parrilla, Juan Carlos</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">International Alliance of Patients' Organizations, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Sehmi, Kawaldip</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">University of Sheffield, UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Stevenson, Matthew D</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">National Institute for Health and Care Excellence (NICE), UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Upadhyaya, Sheela</subfield>
  </datafield>
  <datafield tag="700" ind1=" " ind2=" ">
    <subfield code="u">National Institute for Health and Care Excellence (NICE), UK</subfield>
    <subfield code="4">oth</subfield>
    <subfield code="a">Walker, Thomas</subfield>
  </datafield>
  <datafield tag="856" ind1="4" ind2=" ">
    <subfield code="s">1204681</subfield>
    <subfield code="z">md5:254b27e5e28aa2d1126b2671cac178c6</subfield>
    <subfield code="u">https://zenodo.org/record/5530468/files/HTx-COVID-Guidance for HTA-Project report-V1.1_For publication.pdf</subfield>
  </datafield>
  <datafield tag="542" ind1=" " ind2=" ">
    <subfield code="l">open</subfield>
  </datafield>
  <datafield tag="260" ind1=" " ind2=" ">
    <subfield code="c">2021-09-27</subfield>
  </datafield>
  <datafield tag="909" ind1="C" ind2="O">
    <subfield code="p">openaire</subfield>
    <subfield code="p">user-covid-19</subfield>
    <subfield code="o">oai:zenodo.org:5530468</subfield>
  </datafield>
  <datafield tag="100" ind1=" " ind2=" ">
    <subfield code="u">1. Science Policy and Research Programme, National Institute for Health and Care Excellence (NICE)</subfield>
    <subfield code="a">Elvidge, Jamie</subfield>
  </datafield>
  <datafield tag="245" ind1=" " ind2=" ">
    <subfield code="a">Best-practice guidance for the health technology assessment of diagnostics and treatments for COVID-19</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">user-covid-19</subfield>
  </datafield>
  <datafield tag="536" ind1=" " ind2=" ">
    <subfield code="c">825162</subfield>
    <subfield code="a">Next Generation Health Technology Assessment to support patient-centred, societally oriented, real-time decision-making on access and reimbursement for health technologies throughout Europe</subfield>
  </datafield>
  <datafield tag="540" ind1=" " ind2=" ">
    <subfield code="u">https://creativecommons.org/licenses/by/4.0/legalcode</subfield>
    <subfield code="a">Creative Commons Attribution 4.0 International</subfield>
  </datafield>
  <datafield tag="650" ind1="1" ind2="7">
    <subfield code="a">cc-by</subfield>
    <subfield code="2">opendefinition.org</subfield>
  </datafield>
  <datafield tag="520" ind1=" " ind2=" ">
    <subfield code="a">&lt;p&gt;To support HTA agencies with consistent and pragmatic approaches, we have developed this best-practice guidance for the assessment of technologies for COVID-19. We focused on diagnostic and therapeutic technologies, as the most commonly assessed by HTA agencies. For therapeutics, we focused on treatments rather than post-exposure prophylaxis, however, the recommended approach is unlikely to be much different for prophylactic options.&lt;/p&gt;

&lt;p&gt;The recommendations herein are based on findings from a survey and workshop of HTA agencies, a workshop with health economic modellers, and reviews of COVID-19 methods guidance, clinical guidelines, and economic evaluations. They have also been discussed with, and refined with input from, a multi-stakeholder group at a policy sandbox event. The recommendations span several themes relevant to HTA, and some of the key proposals are summarised below. Foremost among them is the recommendation that the pandemic is used as an opportunity to implement a responsive, &amp;ldquo;living&amp;rdquo; approach to HTA.&lt;/p&gt;</subfield>
  </datafield>
  <datafield tag="773" ind1=" " ind2=" ">
    <subfield code="n">doi</subfield>
    <subfield code="i">isVersionOf</subfield>
    <subfield code="a">10.5281/zenodo.5530467</subfield>
  </datafield>
  <datafield tag="024" ind1=" " ind2=" ">
    <subfield code="a">10.5281/zenodo.5530468</subfield>
    <subfield code="2">doi</subfield>
  </datafield>
  <datafield tag="980" ind1=" " ind2=" ">
    <subfield code="a">publication</subfield>
    <subfield code="b">report</subfield>
  </datafield>
</record>
954
487
views
downloads
All versions This version
Views 954954
Downloads 487487
Data volume 586.7 MB586.7 MB
Unique views 848848
Unique downloads 433433

Share

Cite as